Additional file 5: Figure S3. of Nivolumab dose selection: challenges, opportunities, and lessons learned for cancer immunotherapy

Autor: Agrawal, Shruti, Feng, Yan, Roy, Amit, Kollia, Georgia, Lestini, Brian
Rok vydání: 2016
Předmět:
DOI: 10.6084/m9.figshare.c.3600212_d2.v1
Popis: Exposure-response for efficacy of nivolumab by dose level in RCC. (A) Probability of OR vs Cminss, overall and by dose. (B) Probability of OR vs CL, overall and by dose. CL = clearance; Cminss = steady-state trough concentration; OR = objective response; RCC = renal cell carcinoma. (PDF 697 kb)
Databáze: OpenAIRE